Curium in Finland A legacy of excellence in nuclear medicine

Curium in Finland supports reliable access to nuclear medicine across Finland, Scandinavia and the Baltics through trusted local expertise and global capabilities.

 

80

Dedicated employees

20+

Years' experience

60+

Global customers

20+

Countries

3

Manufacturing facilities

About Curium in Finland

For more than 20 years, Curium in Finland has supported healthcare providers with reliable radiopharmaceutical solutions, combining strong local expertise with the global capabilities of Curium.

Operating GMP-certified facilities in Helsinki and Tikkakoski, the company supports customers across more than 20 countries with a dedicated team of 80 employees committed to quality, reliability, and patient care.

A strong local foundation
Founded in 1991 as MAP Medical Technologies Oy, Curium in Finland has built a strong reputation for operational excellence and regulatory expertise. Since joining Curium in 2019, the company has further strengthened its ability to deliver high-quality radiopharmaceutical solutions across the region.

Reliable operations and supply
With three manufacturing facilities and wholesale distribution authorisation for medicinal products in Finland, Curium in Finland plays an important role in supporting consistent access to nuclear medicine throughout Scandinavia and the Baltics. Its operations are designed to ensure dependable supply, quality assurance, and efficient delivery to healthcare providers.

Connected to a global network
As part of Curium’s international organisation, Curium in Finland combines local knowledge with global scale, helping advance nuclear medicine through trusted partnerships, specialised expertise, and a shared commitment to improving patient care.

Curium products in Finland

Comprehensive radiopharmaceutical portfolio

Curium in Finland manufactures a growing portfolio of radiopharmaceutical solutions supporting both diagnostic imaging and targeted therapies.

Approved products include Pylclari and Fludeomap, while several innovative solutions are currently in development, including [18F] Sodium Fluoride (NaF) for injection, (18F) Fluorocholine chloride solution for injection, [177Lu] Lu-PSMA I&T solution for injection, and [225Ac] Actinium-PSMA I&T solution for injection.

Curium in Finland Locations

Finland

Location type

Country Headquarters

Address
Kivihaantie 7 F
FI-00310 Helsinki
Finland

Helsinki (Kivihaka)

Location type

Sales Offices, Manufacturing Sites

Address
Curium Finland Oy
Kivihaantie 7 F
FI-00310 Helsinki
Finland

Helsinki (Saukonpaasi)

Location type

Manufacturing Sites, PET Radiopharmacies

Address
Saukonpaadenranta 2
FI-00180 Helsinki
Finland

Tikkakoski

Location type

Sales Offices, Manufacturing Sites

Address
Elementtitie 27
FI-41160 Tikkakoski
Finland

Finland's Financial Contributions

2025